Literature DB >> 26419384

What is new about diet in hepatic encephalopathy.

Manuela Merli1, Valerio Iebba2, Michela Giusto3.   

Abstract

There is a relationship between hepatic encephalopathy (HE) protein malnutrition and muscle wasting. Muscle may play an alternative role in ammonia detoxification. Molecular mechanisms responsible for muscle depletion are under investigation. Specific nutrients may interact to reverse the molecular pathways involved in muscle wasting at an early stage. Training exercises have also been proposed to improve skeletal muscle mass. However, these data refer to small groups of patients. The amelioration of muscle mass may potentially help to prevent HE. The pathogenesis of HE is associated with modifications of the gut microbiota and diet is emerging to play a relevant role in the modulation of the gut milieu. Vegetarian and fibre-rich diets have been shown to induce beneficial changes on gut microbiota in healthy people, with reduction of Bacteroides spp., Enterobacteriaceae, and Clostridium cluster XIVa bacteria. By way of contrast, it has been suggested that a high-fat or protein diet may increase Firmicutes and reduce Bacteroidetes phylum. Milk-lysozyme and milk-oligosaccharides have also been proposed to induce a "healthy" microbiota. At present, no studies have been published describing the modification of the gut microbiota in cirrhotic patients with HE as a response to specific diets. New research is needed to evaluate the potentiality of foods in the modulation of gut microbiota in liver disease and HE.

Entities:  

Keywords:  Cirrhosis; Fibres; Gut microbiota; Nutrition; Sarcopenia; Vegetables

Mesh:

Substances:

Year:  2015        PMID: 26419384     DOI: 10.1007/s11011-015-9734-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  47 in total

1.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

Authors:  K B M Saiful Islam; Satoru Fukiya; Masahito Hagio; Nobuyuki Fujii; Satoshi Ishizuka; Tadasuke Ooka; Yoshitoshi Ogura; Tetsuya Hayashi; Atsushi Yokota
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

2.  Characterization of bacteria, clostridia and Bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting.

Authors:  Kathrin Liszt; Jutta Zwielehner; Michael Handschur; Berit Hippe; Roman Thaler; Alexander G Haslberger
Journal:  Ann Nutr Metab       Date:  2009-07-27       Impact factor: 3.374

Review 3.  Human milk and related oligosaccharides as prebiotics.

Authors:  Daniela Barile; Robert A Rastall
Journal:  Curr Opin Biotechnol       Date:  2013-02-19       Impact factor: 9.740

4.  Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.

Authors:  Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers
Journal:  Liver Transpl       Date:  2012-10       Impact factor: 5.799

5.  Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis.

Authors:  Jia Qiu; Cynthia Tsien; Samjhana Thapalaya; Arvind Narayanan; Conrad Chris Weihl; James K Ching; Bijan Eghtesad; Kamini Singh; Xiaoming Fu; George Dubyak; Christine McDonald; Alex Almasan; Stanley L Hazen; Sathyamangla V Naga Prasad; Srinivasan Dasarathy
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-14       Impact factor: 4.310

Review 6.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

7.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

Review 8.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  High-fat diet determines the composition of the murine gut microbiome independently of obesity.

Authors:  Marie A Hildebrandt; Christian Hoffmann; Scott A Sherrill-Mix; Sue A Keilbaugh; Micah Hamady; Ying-Yu Chen; Rob Knight; Rexford S Ahima; Frederic Bushman; Gary D Wu
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

10.  Large-scale survey of gut microbiota associated with MHE Via 16S rRNA-based pyrosequencing.

Authors:  Zhigang Zhang; Huiqin Zhai; Jiawei Geng; Rui Yu; Haiqing Ren; Hong Fan; Peng Shi
Journal:  Am J Gastroenterol       Date:  2013-07-23       Impact factor: 10.864

View more
  12 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Practical Issues in the Management of Overt Hepatic Encephalopathy.

Authors:  Ganesh Pantham; Kevin D Mullen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-11

Review 3.  Nutrition and Muscle in Cirrhosis.

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-11-08

4.  A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Authors:  Ganesh Pantham; Anthony Post; Deepak Venkat; Douglas Einstadter; Kevin D Mullen
Journal:  Dig Dis Sci       Date:  2017-05-30       Impact factor: 3.199

Review 5.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

Review 6.  Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis.

Authors:  Daniela Campion; Ilaria Giovo; Paola Ponzo; Giorgio M Saracco; Federico Balzola; Carlo Alessandria
Journal:  World J Hepatol       Date:  2019-06-27

Review 7.  Malnutrition in Patients with Liver Cirrhosis.

Authors:  Julia Traub; Lisa Reiss; Benard Aliwa; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2021-02-07       Impact factor: 5.717

Review 8.  Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.

Authors:  Fatuma Meyer; Karen Bannert; Mats Wiese; Susanne Esau; Lea F Sautter; Luise Ehlers; Ali A Aghdassi; Cornelia C Metges; Leif-A Garbe; Robert Jaster; Markus M Lerch; Georg Lamprecht; Luzia Valentini
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

Review 9.  Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Authors:  Jiachen Liu; Yantao Xu; Bimei Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

10.  Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.

Authors:  Elisabetta Margiotta; Lara Caldiroli; Maria Luisa Callegari; Francesco Miragoli; Francesca Zanoni; Silvia Armelloni; Vittoria Rizzo; Piergiorgio Messa; Simone Vettoretti
Journal:  Toxins (Basel)       Date:  2021-07-08       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.